Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Long-Term Investments (2020 - 2025)

Updated

Analysis

Rallybio (RLYB) Long-Term Investments (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Rallybio 84.05 Mn -201.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 626,000.00
Mar 31, 2025 413,000.00
Sep 30, 2024 431,000.00
Jun 30, 2024 568,000.00
Mar 31, 2024 304,000.00
Dec 31, 2023 239,000.00
Sep 30, 2023 102,000.00
Mar 31, 2023 217,000.00
Dec 31, 2022 30,000.00
Sep 30, 2022 244,000.00
Jun 30, 2022 227,000.00
Mar 31, 2022 415,000.00
Dec 31, 2021 805,000.00
Sep 30, 2021 1.03 Mn
Jun 30, 2021 1.36 Mn
Dec 31, 2020 310,000.00
API Access

Rallybio Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RLYB&period=max&api_key=YOUR_API_KEY